Human FIA / Tumor Markers
CA19-9 FIA Test
A fluorescence immunochromatographic quantitative assay for CA19-9 (Cancer antigen 19-9), designed for professional POCT and clinical laboratory workflows.
SpecimenWB/Serum/Plasma
Pack size25 Tests/Kit
Time to result10-15 min
Professional IVD useIVD / POCT
Product Features
Quantitative fluorescence readout
Instrument-based fluorescence reading provides objective quantitative results and reduces visual interpretation variation.
Rapid POCT workflow
A clear sample, incubation and reader workflow supports fast turnaround in clinics, emergency rooms and laboratories.
Lot traceability
Lot calibration, QC records and retained-sample management support professional quality systems.
Broad assay menu
One FIA platform can cover inflammation, cardiac, tumor, endocrine, infectious disease and other clinical menus.
Technical Specifications
| Method | Fluorescence immunochromatographic assay (FIA) |
|---|---|
| Specimen | WB/Serum/Plasma |
| Format | FIA test cassette / kit |
| Result type | Quantitative result with automated reader interpretation |
| Time to result | Approx. 10-15 minutes; refer to assay IFU |
| Storage | 2-30°C, dry and protected from light |
| Pack size | 25 Tests/Kit; customized pack sizes available |
| Analyzer | Safheal fluorescence immunoassay analyzer / compatible FIA reader |
| QC & calibration | Built-in control line with lot-specific calibration traceability |
| Measuring range | Assay-specific; refer to IFU or COA |
Testing Workflow
01
Sample
Add sample and buffer
02
React
Incubate by assay protocol
03
Read
Measure fluorescence signal
04
Report
Output quantitative result